Getting the timing right

Drug and Therapeutics Bulletin

Volumn 50, Issue 2, 2012, Pages 13-14

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM;

DRUG EFFICACY; DRUG SAFETY; HEALTH CARE; HEALTH CARE PERSONNEL; HUMAN; NOTE; PRACTICE GUIDELINE; PRESCRIPTION; QT PROLONGATION;

DRUG INFORMATION SERVICES; DRUG TOXICITY; EUROPE;

EID: 84857134686     PISSN: 00126543     EISSN: 17555248     Source Type: Journal    
DOI: 10.1136/dtb.2012.02.0082     Document Type: Note

References (4)

1. Datapharm Communications Ltd., 2012. Electronic medicines compendium [online]. Available: http://www.medicines.org.uk/EMC/default.aspx [Accessed 19 January 2012].
2. Why look at an SPC? DTB, 2009; 48: 56-8.
3. European Commission, 2009. A Guideline on Summary of Product Characteristics (SmPC), September 2009 [online]. Available: http://ec.europa.eu/health/files/eudralex/vol-2/c/smpc_guideline_rev2_en.pdf [Accessed 19 January 2012].
4. Medicines and Healthcare products Regulatory Agency, 2011. Citalopram and escitalopram: QT interval prolongation - new maximum daily dose restrictions (including in elderly patients), contraindications, and warnings. Drug Safety Update, 2011; 5 (5): A1 [online]. Available: http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON137769 [Accessed 19 January 2012].